Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy
2025/04/23 by Sándor Beniczky, Eugen Trinka, Elaine Wirrell +54 · 1 voice · 43 citations
Medicine · #Epilepsy research and treatment #Neonatal and fetal brain pathology #Pharmacological Effects and Toxicity Studies
paper · doi:10.1111/epi.18338
Abstract
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic-clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource-limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
Citations
Cited by
- Photosensitivity in Lafora and Unverricht–Lundborg progressive myoclonic epilepsies
- Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
- Classifying seizure generation mechanisms: A critical transitions framework
- Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
- Genetic complexity in pediatric onset epilepsy‐movement disorder syndromes: Insights from a cohort of 97 subjects
- Applicability and feasibility of the updated ILAE seizure classification in secondary referral centers
- Syndromic and etiological classification predicts seizure freedom in childhood and youth onset epilepsy: A population‐based study from the Norwegian Mother, Father, and Child Cohort Study
- Late‐onset epilepsy of unknown etiology is more treatment‐responsive than acquired lesional late‐onset epilepsy
- Feasibility and safety of awake craniotomy in adult patients with drug‐resistant focal epilepsy
- Real‐world use of cenobamate in pediatric focal epilepsies and developmental epileptic encephalopathies: A multicenter retrospective series
- Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology
- Reducing unnecessary investigations in pediatric simple febrile and first-episode generalized unprovoked seizures
- Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial ( PACIFIC )
- Spanish translation, adaptation, and validation of the Epilepsy Surgery Satisfaction Questionnaire‐19
- Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy
- Anti‐γ‐aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights
- Surprising epileptic semiology in seventeenth-century beatification testimonies: A neuropsychiatric analysis of St. Joseph of Copertino
- Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE
- Symptom network analysis of prefrontal seizures. [europepmc]
- Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy. [europepmc]
- Multistage Molecular Simulations, Design, Synthesis, and Anticonvulsant Evaluation of 2-(Isoindolin-2-yl) Esters of Aromatic Amino Acids Targeting GABA A Receptors via π-π Stacking. [europepmc]
- Epilepsy as a dynamic disease: Toward actionable, individualized seizure risk prediction. [europepmc]
- Feasibility and safety of awake craniotomy in adult patients with drug-resistant focal epilepsy. [europepmc]
- Early seizure freedom with [ 18 F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report. [europepmc]
- Anti-γ-aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights. [europepmc]
- Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug-resistant epilepsy. [europepmc]
- Late-onset epilepsy of unknown etiology is more treatment-responsive than acquired lesional late-onset epilepsy. [europepmc]
- A practical guide to the updated seizure classification 2025. [europepmc]
- Using stereo-electroencephalography data to model the optimal intracranial venous sinus location for an endovascular seizure detection device: A feasibility study. [europepmc]
- Genetic complexity in pediatric onset epilepsy-movement disorder syndromes: Insights from a cohort of 97 subjects. [europepmc]
- Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial (PACIFIC). [europepmc]
- Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology. [europepmc]
- Effectiveness of a high-fidelity simulation program based on flipped learning for nurses' emergency management of seizures: a mixed-methods design. [europepmc]
- Dynamics of early electroencephalographic patterns and epileptic seizures in acute intracerebral hemorrhage: A prospective controlled study. [europepmc]
- The neuroendocrine puzzle of epilepsy and infertility: what are we missing? [europepmc]
- Incidence and clinical predictors of epilepsy after febrile seizures in children: A prospective cohort study in Vietnam. [europepmc]
- Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure. [europepmc]
- Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE. [europepmc]
- Persons with epilepsy and their caregivers understand the definition of ictal impairment of consciousness. [europepmc]
- Prognostic factors and a preliminary prognostic model in anti-GAD antibody-associated epilepsy. [europepmc]
- Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology. [europepmc]
- Therapeutic Potential Target of Adenosine for Epilepsy: Focusing on Its Interaction with the Molecular Epileptogenic Network. [europepmc]
- Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results. [europepmc]
Discussions
Related